Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
6 Hong Kong Virtual Asset ETFs Traded at HK$22,805,800 Today

6 Hong Kong Virtual Asset ETFs Traded at HK$22,805,800 Today

Bitget2024/07/29 08:34

Hong Kong stock market data shows that as of the close of trading, the turnover of 6 Hong Kong virtual asset ETFs today was HK$22,805,800,000, among which: the turnover of Huaxia Bitcoin ETF (3042.HK) was HK$12,210,000, the turnover of Huaxia Ether ETF (3046.HK) was HK$2,980,000, the turnover of Harvest Bitcoin ETF (3439.HK) was HK$3,370,000, and the turnover of Harvest Ether ETF (3179.HK) was HK$1,190,000, and the turnover of Boshi HashK ETF (3179.HK) was HK$3,377,000 million, Harvest Ether ETF (3179.HK) with HK$1.19 million, Bosera HashKey Bitcoin ETF (3008.HK) with HK$2,269,600, and Bosera HashKey Ether ETF (3009.HK) with HK$786,200.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage